About us Newsroom


Heidelberg University Hospital

Find the latest news and press releases about Heidelberg University Hospital in Germany and learn more about our medical departments, our state-of-the-art technology or new treatment options in Heidelberg.

  • Treating Cancer with Ion Beam Therapy Award for Scientific and Technical Director at HIT

    Latest News | 16.07.2021

    European Physical Society (EPS) awarded the IBA-Europhysics Prize to Prof. Thomas Haberer for his scientific and technical contribution in the development of Heidelberg Ion Beam Therapy Center. The treatment with Ion radiation more precis, more effective than...

    Read Article
  •  shorter radiation therapy
    Radiation Therapy at Heidelberg University Hospital - Shorter radiation duration, equivalent treatment result

    Latest News | 16.06.2021

    Study: Shorter Radiation Duration:Shorter radiation duration, equivalent treatment result. A relief for the patients and increase of the quality of life...

    Read Article
  • a pioneer in the treatment of pancreatic cancer
    Clinical Cancer Research - German Cancer Award 2021

    Latest News | 16.06.2021

    German Cancer Award 2021 for Prof. Markus Büchler as a pioneer in the treatment of pancreatic cancer. The award ceremony has been broadcasted live from the Berlin-Brandenburg Academy of Sciences and Humanities for the interested public / Büchler honoured as a pioneer in the treatment of pancreatic cancer...

    Read Article
  • Heidelberg University Hospital ranks among the WORLD'S BEST HOSPITALS 2021

    Latest News, Preise | 26.04.2021

    Heidelberg University Hospital ranks among the "WORLD'S BEST HOSPITALS 2021" for the third year in row

    Read Article
  • Professor Büchler in surgery
    German Cancer Award For Heidelberg Surgeon Markus Büchler

    Surgery Center | 08.03.2021

    Prof. Markus W. Büchler, MD, was awarded the German Cancer Prize 2021 in the "clinical research" category on February 3 for his contributions to improving the treatment of pancreatic cancer.

    Read Article
Subscribe to our international infoletter